Lymphoma Treatment: Chemotherapy

Chemotherapy is the use of drugs to kill cancer cells and shrink tumors. Each drug has one or more methods to kill cells - most stop certain cell growth by interrupting the cell division process.

Chemotherapy is called a systemic treatment because the drugs enter the bloodstream, travel through the body, and can kill cancer cells throughout the body.

Chemotherapy is delivered many different ways depending on the drugs and treatment. Intravenous means delivered by inserting a needle in a vein, orally is by mouth, and via catheter or port is by a tube inserted into the chest via a surgical procedure.

Combination Chemotherapy is the use of a number of drugs together to combat the cancer. They often have acronyms for names like CHOP and ABVD.

Bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) are the use of high doses of chemotherapy with a rescue of the immune system afterwards. More on the Transplantation Information Page.

Clinical trials are new treatments often used for people who are not responsive to conventional treatment or who wish to help researchers test new therapies.

Chemotherapy can be very tough on both body and spirit. Side effects are common - some drugs cause hair loss, nausea, and low blood cell counts. The side effects vary by drug and combination of drugs. You can read more about these effects when researching individual drugs and drug combinations.

Chemotherapy is the culmination of years of research and clinical trials - many of the mainstream combinations are very effective treatments. New drugs are in development by many pharmaceutical companies, promising new, effective treatments.

 

Resources

Chemotherapy Drugs

There are many, many different drugs currently in use for cancer and a number of those are used for lymphoma:

A List of Drugs and Drug Information Resources

Chemotherapy Regimes

Hodgkin's Disease: ABVD, Stanford V, MOPP

Non-Hodgkin's Lymphoma: CHOP

Catheters

See the updated page The Facts About Intravenous Catheter Lines

Side Effects

Peripheral Neuropathy - nerve damage from chemotherapy (do your feet or hands tingle?)

Hair loss (alopecia) is common with some chemotherapy drugs. Headcoverings may help cope.

Supportive Care

Surviving Lymphoma - information on helpful issues

Coping Information from NCI

Support Information from NCI

Bone Marrow and Peripheral Blood Cell Information

Bone Marrow / Peripheral Blood Stem Cell Transplant Information Page

Clinical Trials

Trial information is on a new Trial Page

 

Related Articles

Return Links - Therapy:

[Chemo Drugs] [Radiotherapy] [Immunotherapy] [Transplants]

Return Links - Conditions:

[Adult Hodgkin's] [Adult Non-Hodgkin's]

[Childhood Hodgkin's] [Childhood Non-Hodgkin's]

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap